- SG$308.12m
- SG$210.07m
- SG$653.93m
- 89
- 88
- 65
- 97
Annual income statement for Multi-Chem, fiscal year end - December 31st, SGD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 604 | 617 | 658 | 684 | 654 |
| Cost of Revenue | |||||
| Gross Profit | 85.5 | 81.9 | 94.8 | 97.5 | 89.6 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 568 | 591 | 621 | 642 | 617 |
| Operating Profit | 35.7 | 25.8 | 37.7 | 41.2 | 36.8 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 36 | 25.6 | 36.5 | 38.8 | 33 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 27.3 | 20 | 27.1 | 30.8 | 26.4 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 25 | 20 | 27.1 | 30.8 | 26.4 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 25 | 20 | 27.1 | 30.8 | 26.4 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.271 | 0.223 | 0.307 | 0.348 | 0.293 |
| Dividends per Share |